Satellos Bioscience (MSLE) Beginning Cash Balance (2025 - 2026)
Satellos Bioscience (MSLE) reported Beginning Cash Balance of $9.8 million for the quarter ended Mar 31, 2026, down 75.5% from $40.07 million a year earlier.
Powered by 
Analysis
Satellos Bioscience (MSLE) Beginning Cash Balance (2025 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Satellos Bioscience posted Beginning Cash Balance of $40.07 million, up 140.2% from the prior year.
- By year, Beginning Cash Balance came in at $16.68 million in the year ended Dec 31, 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Satellos Bioscience | 131.40 Mn | 131.40 Mn | - |
API Access
Satellos Bioscience Beginning Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=beginning-cash-balance&ticker=MSLE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "beginning-cash-balance", "ticker": "MSLE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=beginning-cash-balance&ticker=MSLE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();